Page last updated: 2024-10-28

hexamethonium and Peritonitis

hexamethonium has been researched along with Peritonitis in 1 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Peritonitis: INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brunsson, I1
Fahrenkrug, J1
Jodal, M1
Sjöqvist, A1
Theodorsson, E1
Lundgren, O1

Other Studies

1 other study available for hexamethonium and Peritonitis

ArticleYear
On the role of vasoactive intestinal polypeptide and tachykinins in the secretory reflex elicited by chemical peritonitis in the cat small intestine.
    Acta physiologica Scandinavica, 1990, Volume: 139, Issue:1

    Topics: Animals; Biological Transport; Body Fluids; Cats; Enkephalin, Methionine; Female; Ganglionic Blocker

1990